Kaur N - Search Results

1

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Fischer M, Kao D, Kelly C, Kuchipudi A, Jafri SM, Blumenkehl M, Rex D, Mellow M, Kaur N, Sokol H, Cook G, Hamilton MJ, Phelps E, Sipe B, Xu H, Allegretti JR. Fischer M, et al. Among authors: kaur n. Inflamm Bowel Dis. 2016 Oct;22(10):2402-9. doi: 10.1097/MIB.0000000000000908. Inflamm Bowel Dis. 2016. PMID: 27580384

2

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.

Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M. Cheng YW, et al. Among authors: kaur n. Am J Transplant. 2019 Feb;19(2):501-511. doi: 10.1111/ajt.15058. Epub 2018 Aug 31. Am J Transplant. 2019. PMID: 30085388 Free PMC article.

3

Intestinal dysbiosis in inflammatory bowel disease.

Kaur N, Chen CC, Luther J, Kao JY. Kaur N, et al. Gut Microbes. 2011 Jul-Aug;2(4):211-6. doi: 10.4161/gmic.2.4.17863. Epub 2011 Jul 1. Gut Microbes. 2011. PMID: 21983063 Free article. Review.

4

Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis.

Parekh R, Abdulhamid A, Trudeau S, Kaur N. Parekh R, et al. Among authors: kaur n. Case Rep Gastrointest Med. 2018 May 15;2018:1015408. doi: 10.1155/2018/1015408. eCollection 2018. Case Rep Gastrointest Med. 2018. PMID: 29862092 Free PMC article.

5

Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease.

Tse CS, Van Citters AD, Ricci B, Freundlich NZ, Lee M, Shah SA, Melmed GY, Siegel CA, van Deen WK; IBD Qorus. Tse CS, et al. J Crohns Colitis. 2022 Mar 14;16(3):379-388. doi: 10.1093/ecco-jcc/jjab142. J Crohns Colitis. 2022. PMID: 34350943

6

Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment.

Kamp KJ, Hawes SE, Tse CS, Singh S, Dang N, Oberai R, Weaver SA, Melmed GY, Siegel CA, van Deen WK; IBD Qorus. Kamp KJ, et al. Inflamm Bowel Dis. 2023 Aug 1;29(8):1255-1262. doi: 10.1093/ibd/izac206. Inflamm Bowel Dis. 2023. PMID: 36179129 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 35006185

8

P059 Impact of PHQ-9 Screen on Early Identification of Depression in IBD Clinic.

Nagirimadugu A, Patel A, Nimri F, Musleh M, Naffouj S, Faber A, Abu Ghanimeh M, Kaur N. Nagirimadugu A, et al. Among authors: kaur n. Am J Gastroenterol. 2021 Dec 1;116(Suppl 1):S15. doi: 10.14309/01.ajg.0000798836.33683.7f. Am J Gastroenterol. 2021. PMID: 37461976

9

Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.

Parekh R, Kaur N. Parekh R, et al. Among authors: kaur n. Case Rep Gastrointest Med. 2014;2014:956463. doi: 10.1155/2014/956463. Epub 2014 Jan 19. Case Rep Gastrointest Med. 2014. PMID: 24707412 Free PMC article.

10

Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

Abdalla T, Lowes MA, Kaur N, Micheletti RG, Steinhart AH, Alavi A. Abdalla T, et al. Among authors: kaur n. Am J Clin Dermatol. 2021 Mar;22(2):139-147. doi: 10.1007/s40257-020-00579-z. Am J Clin Dermatol. 2021. PMID: 33398848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,485 results

Search Page

Filters